Clinical Trial Update: SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis. [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports completion of the SUMMIT study evaluating monthly persistence to Bonviva (ibandronate) in women with postmenopausal osteoporos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Post Menopausal Osteoporosis | Phase 4 | Status: COMPLETED